Critic at Large

» public health, science publishing and opinion

Most Recent

image: Never Say Never

Never Say Never

By | February 1, 2012

Novel observations can sometimes be correct for unexpected reasons.

12 Comments

image: An Evolving Science for an Evolving Time

An Evolving Science for an Evolving Time

By | January 1, 2012

Twenty-first century challenges to the public health of all the world’s populations require forward-looking commitments from epidemiologists.

12 Comments

image: From Test Tube to Hypodermic Needle

From Test Tube to Hypodermic Needle

By | December 1, 2011

A prescription for educating the public on the value of using animals in medical research

40 Comments

image: Avoiding Animal Testing

Avoiding Animal Testing

By | December 1, 2011

Advances in cell-culture technologies are paving the way to the complete elimination of animals from the laboratory.

82 Comments

image: Hard and Harder

Hard and Harder

By | June 5, 2011

The path to eradicating malaria in Africa involves much more than just a vaccine.

18 Comments

image: At the Tipping Point

At the Tipping Point

By | February 1, 2011

Data standards need to be introduced—now.

0 Comments

Popular Now

  1. UC Berkeley Receives CRISPR Patent in Europe
    Daily News UC Berkeley Receives CRISPR Patent in Europe

    The European Patent Office will grant patent rights over the use of CRISPR in all cell types to a University of California team, contrasting with a recent decision in the U.S.

  2. DNA Replication Errors Contribute to Cancer Risk
  3. Should Healthy People Have Their Exomes Sequenced?
    Daily News Should Healthy People Have Their Exomes Sequenced?

    With its announced launch of a whole-exome sequencing service for apparently healthy individuals, Ambry Genetics is the latest company to enter this growing market. But whether these services are useful for most people remains up for debate.  

  4. Rethinking a Cancer Drug Target
    Daily News Rethinking a Cancer Drug Target

    The results of a CRISPR-Cas9 study suggest that MELK—a protein thought to play a critical role in cancer—is not necessary for cancer cell survival.

Business Birmingham